Market revenue in 2023 | USD 79.9 million |
Market revenue in 2030 | USD 286.2 million |
Growth rate | 20% (CAGR from 2023 to 2030) |
Largest segment | Nucleic acid aptamer |
Fastest growing segment | Nucleic Acid Aptamer |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Nucleic Acid Aptamer, Peptide Aptamer |
Key market players worldwide | Aptadel Therapeutics, Tencent Music Entertainment Group ADR, Vivonics, Aptamer Group, TriLink BioTechnologies, Base Pair Biotechnologies, SomaLogic, Aptagen, Altermune Technologies |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to aptamers market will help companies and investors design strategic landscapes.
Nucleic acid aptamer was the largest segment with a revenue share of 78.72% in 2023. Horizon Databook has segmented the Middle East & Africa aptamers market based on nucleic acid aptamer, peptide aptamer covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa aptamers market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa aptamers market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account